India's pharma market has introduced 3,151 new brands in the past year, with AstraZeneca's cancer drug Enhertu becoming the ...

Intravenous Opdivo, with $2.48 billion in sales, topped the list of precision oncology products in BMS's growth portfolio.

High-resolution esophageal manometry plays an essential role in diagnosing the highly prevalent esophageal motility problems in rheumatoid diseases.

Aspirin reduced recurrence by 50% in PIK3CA-mutated colorectal cancer, the DCISionRT test earned FDA breakthrough status for predicting radiotherapy benefit in DCIS, and nivolumab plus chemotherapy ...

Frontline treatment with Tevimbra plus irinotecan, paclitaxel, oxaliplatin and 5-FU/leucovorin had promising efficacy and ...

David B. Zhen, MD, associate professor in the clinical research division of Fred Hutchinson Cancer Center, discusses the results of the phase 3 CheckMate 649 trial (NCT02872116) in patients with ...

In summary, although the lower deep cervical lymph nodes are dispensable relay routes, they can be the last stations on the way of esophageal lymphatic drainage before the venous circulation. They not ...

Leap Therapeutics (NASDAQ:LPTX) fell ~12% on Wednesday as Baird downgraded the stock after the biotech said its lead candidate, sirexatamab, generated disappointing data in a mid-stage trial for ...

If your asthma is uncontrolled, especially if you are having nighttime symptoms, gastroesophageal reflux disease (GERD) may be to blame. As many as 75% of patients with difficult to treat asthma also ...

Shares of Leap Therapeutics, Inc. nosedived more than 70% to an all-time low on Tuesday, making them the top loser across U.S. exchanges. The sharp drop — Leap’s worst intraday fall ever — came after ...

Shares of Leap Therapeutics slid after disappointing initial data from two mid-stage clinical trials of its oncology treatment, resulting in the discontinuation of one clinical program.

Leap Therapeutics (LPTX) lost 63% after announcing it will not run a Phase 3 trial for its lead asset sirexatamab in gastric cancer. Read more here.